Metropolitan Life Insurance Company (MetLife)’s Ansys ANSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,506
Closed -$1.22M 145
2024
Q1
$1.22M Sell
3,506
-27
-0.8% -$9.14K 0.05% 296
2023
Q4
$1.28M Sell
3,533
-58
-2% -$17.2K 0.06% 274
2023
Q3
$1.07M Sell
3,591
-186
-5% -$58.9K 0.06% 287
2023
Q2
$1.25M Sell
3,777
-120
-3% -$38K 0.06% 280
2023
Q1
$1.3M Sell
3,897
-1,141
-23% -$322K 0.07% 271
2022
Q4
$1.22M Sell
5,038
-31
-0.6% -$7.22K 0.05% 322
2022
Q3
$1.12M Sell
5,069
-58
-1% -$14.8K 0.05% 327
2022
Q2
$1.23M Sell
5,127
-144
-3% -$38.1K 0.05% 321
2022
Q1
$1.67M Sell
5,271
-6,276
-54% -$2.05M 0.06% 298
2021
Q4
$4.63M Sell
11,547
-231
-2% -$88.8K 0.06% 245
2021
Q3
$4.01M Sell
11,778
-391
-3% -$141K 0.06% 259
2021
Q2
$4.22M Sell
12,169
-2,804
-19% -$970K 0.06% 261
2021
Q1
$5.08M Sell
14,973
-777
-5% -$276K 0.08% 205
2020
Q4
$5.73M Sell
15,750
-612
-4% -$205K 0.09% 182
2020
Q3
$5.35M Sell
16,362
-680
-4% -$213K 0.09% 176
2020
Q2
$4.97M Buy
17,042
+552
+3% +$147K 0.09% 185
2020
Q1
$3.83M Sell
16,490
-234
-1% -$60.3K 0.08% 208
2019
Q4
$4.3M Buy
16,724
+94
+0.6% +$22.2K 0.07% 244
2019
Q3
$3.68M Buy
16,630
+82
+0.5% +$17.3K 0.06% 258
2019
Q2
$3.39M Buy
16,548
+864
+6% +$165K 0.06% 292
2019
Q1
$2.87M Sell
15,684
-584
-4% -$98.8K 0.05% 315
2018
Q4
$2.33M Sell
16,268
-162
-1% -$25.2K 0.05% 348
2018
Q3
$3.07M Sell
16,430
-348
-2% -$62.3K 0.05% 307
2018
Q2
$2.92M Sell
16,778
-5
-0% -$832 0.05% 333
2018
Q1
$2.63M Sell
16,783
-45
-0.3% -$7.2K 0.04% 382
2017
Q4
$2.48M Sell
16,828
-27,152
-62% -$3.84M 0.03% 422
2017
Q3
$5.4M Sell
43,980
-965
-2% -$121K 0.03% 540
2017
Q2
$5.47M Sell
44,945
-35,608
-44% -$4.2M 0.04% 523
2017
Q1
$8.61M Sell
80,553
-1,253
-2% -$126K 0.06% 312
2016
Q4
$7.57M Sell
81,806
-990
-1% -$91.2K 0.05% 341
2016
Q3
$7.67M Sell
82,796
-943
-1% -$87.9K 0.06% 321
2016
Q2
$7.6M Buy
83,739
+2,974
+4% +$263K 0.06% 324
2016
Q1
$7.22M Buy
80,765
+1,591
+2% +$137K 0.06% 334
2015
Q4
$7.32M Sell
79,174
-621
-0.8% -$57.3K 0.06% 325
2015
Q3
$7.03M Sell
79,795
-374
-0.5% -$34.4K 0.05% 342
2015
Q2
$7.32M Sell
80,169
-138
-0.2% -$12.3K 0.05% 363
2015
Q1
$7.08M Buy
80,307
+1,203
+2% +$102K 0.05% 373
2014
Q4
$6.49M Buy
79,104
+633
+0.8% +$50.2K 0.04% 416
2014
Q3
$5.94M Buy
78,471
+41
+0.1% +$3.21K 0.04% 427
2014
Q2
$5.95M Sell
78,430
-2,589
-3% -$194K 0.04% 454
2014
Q1
$6.24M Buy
81,019
+1,372
+2% +$111K 0.04% 429
2013
Q4
$6.95M Buy
79,647
+483
+0.6% +$41.5K 0.05% 384
2013
Q3
$6.85M Buy
79,164
+243
+0.3% +$20.3K 0.05% 368
2013
Q2
$5.77M Buy
+78,921
New +$5.95M 0.05% 408

Other funds holding ANSS

Metropolitan Life Insurance Company (MetLife)'s ANSS Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Ansys (ANSS) in Q2 2024, closing a stake of 3,506 shares — an estimated $1.22M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ANSS in Q2 2013 and held it in 44 quarters. The position peaked at $8.61M in Q1 2017. 858 funds tracked by Wall St. Rank hold ANSS as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Ansys position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 3,506 Ansys shares in Q2 2024, an estimated $1.22M.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Ansys in Q2 2013 and held it in 44 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Ansys position peaked at $8.61M in Q1 2017.
  • 858 funds tracked by Wall St. Rank held Ansys as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.